Report Code: A15403 | Pages: NA | Mar 2023 | 819 Views | ||
Author(s) : NA | Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Severe Combined Immunodeficiency Market
Request Now !Severe combined immunodeficiency (SCID) is a set of rare disorders caused by various gene mutations. These genes are responsible for the development and functioning of the immune system. SCID is usually life-threatening in the first two years of a child’s life. Immune restoring treatments, such as gene therapy, hematopoietic stem cell therapy (HSCT or bone marrow transplant), and enzyme therapy, can be used to treat these conditions. Among these, HSCT is proven to be the only treatment that entirely cures SCID in babies. Nevertheless, new medicines for the treatment of this condition are being introduced regularly. Gene therapy is still under experimentation and is only considered where bone marrow transplant is not advised for a patient.
SCID affects around 80% of infants who have no family history of the condition. Early detection or screening for SCID helps guarantee that newborns receive life-saving treatments. Adenosine deaminase severe combined immunodeficiency (ADA-SCID), commonly known as bubble syndrome, is a rare genetic condition caused by a mutation in the adenosine deaminase (ADA) gene.
COVID-19 Impact analysis
Pharmaceutical and biotech companies together with governments globally are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges.
Currently, about 115 vaccine samples and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the severe combined immunodeficiency market.
Top Impacting Factors
Market Trends
New Product Launches to Flourish Severe Combined Immunodeficiency MarketÂ
In November 2020, Mustang Bio Inc. partnered with  Minaris Regenerative Medicine in an agreement for technology transfer and GMP production for research on MB-107 lentiviral gene therapy for X-linked severe combined immunodeficiency.
In March 2021, the innovative Genome Institute in collaboration with the University of California, Berkeley, and UC San Francisco received FDA approval for a CRISPR test to correct genetic defects associated with sickle cell disease.
In April 2021, Bioverge Inc. announced the launch of an equity crowd funding platform, Bioverge Portal, for investments in treatments from private healthcare start-ups, via professional healthcare investors.
Key Benefits of Report
Questions Answered in Severe Combined Immunodeficiency Market Report
Severe Combined Immunodeficiency Market Report Highlights
Aspects | Details |
---|---|
By Disease Type |
|
By Treatment |
|
By End User |
|
By Region |
|
Key Market Players | Baxter International Inc., LFB S.A., Biotest AG, Shire Plc, Grifols S.A., Kedrion Biopharma Inc., Sanquin, CSL Behring, China Biologic Products Holdings Inc., Octapharma AG |
Loading Table Of Content...
Start reading.
This Report and over 19,603+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers